Kuros Biosciences AG: management transactions · Switzerland · SIX SER SIX:kuros-biosciences-ag CH0325814116 CH CH · SIX SER Mcap 1.1Bn€
Browse the full management transaction log of Kuros Biosciences AG, a publicly traded company based in Switzerland. Shares trade on CH CH, under the authority of SIX SER. Market capitalisation: €1.1bn. The latest transaction was filed on 16 May 2024 (Purchase). Among the most active insiders: Anonymous (Executive member of the board of directors / member of senior management). All data is accessible without an account.
Financial data FY ended December 2025 · cache
Income statement
Revenue 146.1 M€
Gross profit 129.4 M€ 89% margin
Net income 2.6 M€ 1.7% margin
Balance sheet & cash
Market cap 1.08 Bn€
Total debt 1.4 M€
Free Cash Flow −2.9 M€
Last declaration on 16 May 2024
Declarations 9 total
Executives ● Purchase0 SIX
€72,563 9,000 shares @ €8.0626 CH0325814116⌘
SIX:T1O5G000B9 · 16 May 2024
Ideal exit: 10 Feb 2025 (T+270) Executives ● Sale0 SIX
€3m 390,027 shares @ €8.1569 CH0325814116⌘
SIX:T1O5F00015 · 15 May 2024
Executives ● Sale0 SIX
€2m 212,353 shares @ €8.1569 CH0325814116⌘
SIX:T1O5F00023 · 15 May 2024
Executives ● Sale0 SIX
€228 32 shares @ €7.1392 CH0325814116⌘
SIX:T1O4T00043 · 29 Apr 2024
Executives ● Sale0 SIX
€19,708 2,777 shares @ €7.0969 CH0325814116⌘
SIX:T1O4Q000Z7 · 26 Apr 2024
Executives ● Sale0 SIX
€31,300 4,404 shares @ €7.1071 CH0325814116⌘
SIX:T1O4P000P9 · 25 Apr 2024
Executives ● Purchase25 SIX
€55,206 19,000 shares @ €2.9056 0.0051% mcap 67.4% of flow CH0325814116⌘
SIX:T1O2J00055 · 19 Feb 2024
Ideal exit: 15 Nov 2024 (T+270) Executives ● Sale20 SIX
€17,123 5,867 shares @ €2.9185 0.0016% mcap 20.9% of flow CH0325814116⌘
SIX:T1NC500071 · 5 Dec 2023
Executives ● Sale19 SIX
€9,602 3,000 shares @ €3.2007 0.0009% mcap 11.7% of flow CH0325814116⌘
SIX:T1NBT00060 · 29 Nov 2023